Company Filing History:
Years Active: 2003
Title: Innovations by Peter Dias in Cancer Detection
Introduction
Peter Dias is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of cancer diagnostics, particularly in the detection and classification of neoplasms. His innovative work focuses on improving the accuracy of diagnosing specific subtypes of rhabdomyosarcoma.
Latest Patents
Peter Dias holds a patent for "Compositions and methods for improved detection and classification of neoplasms." This patent describes a method for diagnosing clinically distinct embryonal and alveolar subtypes of rhabdomyosarcoma. The method involves contacting a reagent that includes an antibody specifically binding to myogenin with a sample containing rhabdomyosarcoma cells. By detecting the binding of the antibody to the sample, the presence, absence, or amount of myogenin can be determined, aiding in the diagnosis of these cancer subtypes.
Career Highlights
Peter Dias has dedicated his career to advancing medical diagnostics. His work has been instrumental in enhancing the understanding of rhabdomyosarcoma, a rare and aggressive cancer. He is currently associated with Imgenex, where he continues to innovate in the field of cancer research.
Collaborations
Peter collaborates with Sujay Singh, contributing to the development of new diagnostic methods and technologies. Their partnership aims to further enhance the capabilities of cancer detection and treatment.
Conclusion
Peter Dias is a notable inventor whose work in cancer diagnostics has the potential to significantly impact patient outcomes. His innovative methods for detecting rhabdomyosarcoma exemplify the importance of research and development in the medical field.